Where Innovations Meets Personalized and Precision Medicine
Author = Mozafari, Mohamad
Number of Articles: 2
Clinical Significance and Seroprevalence of L. monocytogenesin in Pregnant Women with Spontaneous Abortion: Personalized Medicine to Improve Outcome (Diagnosis and Monitoring)

Clinical Significance and Seroprevalence of L. monocytogenesin in Pregnant Women with Spontaneous Abortion: Personalized Medicine to Improve Outcome (Diagnosis and Monitoring)

Volume 4, Issue 13, Spring 2019, Pages 10-13

https://doi.org/10.21859/pmj04014

Mahsa Mozaffari, Mohamad Mozafari, Mahdi Mohebbi

Abstract Introduction: Recent scientific promotion reveals that medicine is currently at a transition stage from programmatic to personalized handling on in infectious diseases. Methods: Herrien, this research was performed to evaluation seropositivity for L. monocytogenes based on personalized medicine among the women with and without annals of miscarriage by indirect immunofluorescence test (IIFA). Moreover, the relationship of seropositivity with demographic factors was also investigated. Results: Our outcome showed that 26.92% (35 cases) of women with an involuntary miscarriage were seropositive for L. monocytogenes, while 11% (11 cases) of healthy pregnant women were found positive for L. monocytogenes (P = 0.001). The most case of listeria has been found in age group of 30-35 years old, but no notable difference was found among different groups (P = 0.245). Moreover, there was a considerable association between listeria occurrence and history of abortion when compared with healthy pregnant women (P = 0.001). In addition, early abortion and the number of pregnancy were significantly linked to Listeria- seropositive in patients with spontaneous abortion (P = 0.041; P = 0.034). Conclusions: Further researches are required to appraise the clinical importance of L. monocytogenesin in pregnant women with symptomatic and asymptomatic infection related to personalized medicine.

Investigation of Toxoplasma gondii in Pregnant Women: A Strategy for Personalized Medicine

Investigation of Toxoplasma gondii in Pregnant Women: A Strategy for Personalized Medicine

Volume 4, Issue 13, Spring 2019, Pages 19-22

https://doi.org/10.21859/pmj04016

Mahsa Mozaffari, Mohamad Mozafari, Morvarid Otoukesh, Mohammad Ghaemi, Mahdi Mohebbi

Abstract Introduction: In this study, we evaluated the Seroepidemiology of T. gondii among470 pregnant women as well as association of infection with socio-demographic factors and risk factors such as age, and education was studied, which makes it a potential therapeutic option for personalized medicine. Methods: This cross sectional study was conducted among 470 pregnant women who presented to health centers from February 2013 to January 2014. Serum samples were prepared via a commercial ELISA kit (Euroimmun, Germany) for the attendance of IgG and IgM toxoplasma antibodies and the avidity of the IgG antibody based on the manufacturer’s protocol. Results: We found 34.4% of Toxoplasma IgG. Among 470 pregnant women, 166 cases positive for IgG antibodies toxoplasma were detected, showing a serum incidence of 35.31% (95% confidence interval 27.8 to 37.06%),and thirty eight (22.89%) out of 166 IgG-positive women revealed specific IgM antibodies. Conclusions: Our data showed that the prevalence of T. gondii infection is not related to age, gestational age, number of pregnancies, history of abortion, contact with soil, life in rural areas and education related to infection. as well as these findings may be of major interest for the select of the first-line anti-infection drug, and the urgent require for developing personalized medicine.